Kristallmodifikation von 1-(2,6-Difluorbenzyl)-1H-1,2,3,Triazol-4-Carbons{ureamid und seine Verwendung als Antiepileptikum,申请号DE200712000051C-传众专利搜索

首页产品黄页商标征信

会员服务注册登录

法人/股东/高管

发明名称	Kristallmodifikation von 1-(2,6-Difluorbenzyl)-1H-1,2,3,Triazol-4-Carbons{ureamid und seine Verwendung als Antiepileptikum
摘要
申请公布号	DE122007000051(I1)	申请公布日期	2007.11.08
申请号	DE200712000051C	申请日期	1998.06.08
申请人	NOVARTIS AG	发明人
分类号	A61K31/41;A61K31/4192;A61P25/08;C07D249/04	主分类号	A61K31/41
代理机构		代理人
主权项
地址

您可能感兴趣的专利

Method and system for virtual circuit numbering

Time synchronization system

Radio base station apparatus and base station controller

Method of configuring at least one user-specific connection between access points to a transmission network which are connectable to user-located network devices, and apparatus therefor

Communication method and receiving terminal

Memory optimization packet loss concealment in a voice over packet network

Control channel priority access systems and methods

Communication apparatus, transmission control method, and transmission control program

System for beamforming acoustic buoy fields

Internal source voltage generation circuit and generation method thereof

Fuse circuit and driving method thereof

Fuse monitoring circuit for semiconductor memory device

Content addressable memory with concurrent two-dimensional search capability in both row and column directions

Fly-forward converter power supply

Antireflection film and optical element having same

Sense amplifier and driving method thereof, and semiconductor memory device having the sense amplifier

Efficient erase algorithm for SONOS-type NAND flash

Word line voltage boost system and method for non-volatile memory devices and memory devices and processor-based system using same

Imaging lens and imaging apparatus equipped with the imaging lens